Anna V. Oláh

424 total citations
41 papers, 311 citations indexed

About

Anna V. Oláh is a scholar working on Surgery, Molecular Biology and Physiology. According to data from OpenAlex, Anna V. Oláh has authored 41 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 8 papers in Molecular Biology and 8 papers in Physiology. Recurrent topics in Anna V. Oláh's work include Clinical Laboratory Practices and Quality Control (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Anna V. Oláh is often cited by papers focused on Clinical Laboratory Practices and Quality Control (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Cholesterol and Lipid Metabolism (3 papers). Anna V. Oláh collaborates with scholars based in Hungary, United Kingdom and United States. Anna V. Oláh's co-authors include János Kappelmayer, Csongor Kiss, Edit Bárdi, András Lipták, János Harangi, József Varga, Éva Oláh, Pál Nánási, Csaba Jenei and Emõke Endreffy and has published in prestigious journals such as Nature, International Journal of Molecular Sciences and Annals of the Rheumatic Diseases.

In The Last Decade

Anna V. Oláh

36 papers receiving 295 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna V. Oláh Hungary 11 123 63 42 40 35 41 311
Francesca Leone Italy 14 103 0.8× 71 1.1× 30 0.7× 24 0.6× 26 0.7× 30 404
Takao Sato Japan 9 94 0.8× 45 0.7× 51 1.2× 33 0.8× 14 0.4× 22 422
K Ishii Japan 11 100 0.8× 88 1.4× 40 1.0× 42 1.1× 13 0.4× 52 411
Hüseyin Beğenik Türkiye 11 99 0.8× 63 1.0× 23 0.5× 45 1.1× 50 1.4× 30 374
Tadashi Miyahara Japan 10 91 0.7× 31 0.5× 31 0.7× 19 0.5× 70 2.0× 35 286
Francisco Azzato Argentina 10 70 0.6× 47 0.7× 121 2.9× 28 0.7× 26 0.7× 23 456
Ching‐Shan Huang Taiwan 12 134 1.1× 35 0.6× 67 1.6× 20 0.5× 10 0.3× 28 356
Anita Markotić Croatia 12 136 1.1× 28 0.4× 19 0.5× 110 2.8× 12 0.3× 35 360
Jingchao Liu China 11 152 1.2× 35 0.6× 46 1.1× 45 1.1× 11 0.3× 44 396

Countries citing papers authored by Anna V. Oláh

Since Specialization
Citations

This map shows the geographic impact of Anna V. Oláh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna V. Oláh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna V. Oláh more than expected).

Fields of papers citing papers by Anna V. Oláh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna V. Oláh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna V. Oláh. The network helps show where Anna V. Oláh may publish in the future.

Co-authorship network of co-authors of Anna V. Oláh

This figure shows the co-authorship network connecting the top 25 collaborators of Anna V. Oláh. A scholar is included among the top collaborators of Anna V. Oláh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna V. Oláh. Anna V. Oláh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szegedi, István, Csongor Kiss, Anna V. Oláh, et al.. (2022). The role of urinary N-acetyl-β-D-glucosaminidase in early detection of acute kidney injury among pediatric patients with neoplastic disorders in a retrospective study. BMC Pediatrics. 22(1). 429–429. 7 indexed citations
2.
Bagoly, Zsuzsa, Attila Nagy, Anna V. Oláh, et al.. (2020). Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques. Cardiology Research and Practice. 2020. 1–8. 6 indexed citations
3.
Mádi, András, Ixchelt Cuaranta‐Monroy, Attila Pap, et al.. (2017). Browning deficiency and low mobilization of fatty acids in gonadal white adipose tissue leads to decreased cold-tolerance of transglutaminase 2 knock-out mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1862(12). 1575–1586. 4 indexed citations
4.
Lőrincz, Hajnalka, Mariann Harangi, Anna V. Oláh, et al.. (2015). Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome. Pediatric Research. 77(5). 703–709.
5.
Oláh, Anna V., et al.. (2015). A koleszterin-bioszintézis veleszületett zavara: a Smith–Lemli–Opitz-szindróma. Orvosi Hetilap. 156(42). 1695–1702. 1 indexed citations
6.
Padra, János Tamás, I. Serés, Anna V. Oláh, et al.. (2014). A comparative study on dyslipidaemia inducing diets in various rat strains. Acta Physiologica Hungarica. 101(2). 250–258. 2 indexed citations
7.
Lőrincz, Hajnalka, et al.. (2013). Characterization of a novel high-density lipoprotein antioxidant capacity assay and its application to high-density lipoprotein fractions. Clinical Biochemistry. 46(9). 825–827. 5 indexed citations
8.
Oláh, Anna V., et al.. (2013). Relation between biomarkers and clinical severity in patients with Smith–Lemli–Opitz syndrome. European Journal of Pediatrics. 172(5). 623–630. 17 indexed citations
9.
Tímár, Orsolya, Zoltán Szekanecz, György Kerekes, et al.. (2012). THU0240 Rosuvastatin improves impaired endothelial function and lowers high sensitivity CRP in patients with systemic sclerosis – a prospective case-series study. Annals of the Rheumatic Diseases. 71. 236–236. 1 indexed citations
10.
Balogh, István, Olga Török, Kinga Hadzsiev, et al.. (2012). Mutational Spectrum of Smith-Lemli-Opitz Syndrome Patients in Hungary. Molecular Syndromology. 3(5). 215–222. 16 indexed citations
11.
Oláh, Anna V., László Asztalos, E.‐M. Varga, et al.. (2011). Monitoring of mycophenolic acid and kidney function during combined immunosuppressive therapy. Clinical Chemistry and Laboratory Medicine (CCLM). 49(11). 1849–53. 1 indexed citations
12.
Padra, János Tamás, Gabriella Fóris, Péter Fülöp, et al.. (2010). MS488 EFFECTS OF FLUVASTATIN ON TUMOR DEVELOPMENT AND PARAOXONASE-1 ACTIVITY IN RATS FED WITH CHOLESTEROL-RICH DIET. Atherosclerosis Supplements. 11(2). 208–208.
13.
Oláh, Anna V., et al.. (2009). A patient with Smith–Lemli–Opitz syndrome: novel mutation of the DHCR7 gene and effects of therapy with simvastatin and cholesterol supplement. European Journal of Pediatrics. 169(1). 121–123. 22 indexed citations
14.
Bárdi, Edit, et al.. (2007). Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathology & Oncology Research. 13(3). 249–253. 35 indexed citations
15.
Harangi, Mariann, János Mátyus, Erzsébet Nagy, et al.. (2007). Identification of sulfhemoglobinemia after surgical polypectomy. Clinical Toxicology. 45(2). 189–192. 3 indexed citations
16.
Bárdi, Edit, Anna V. Oláh, Emõke Endreffy, et al.. (2004). Late effects on renal glomerular and tubular function in childhood cancer survivors. Pediatric Blood & Cancer. 43(6). 668–673. 34 indexed citations
17.
Oláh, Anna V., et al.. (2004). Age dependence of serum β-N-acetylhexosaminidase (NAG) activity. Clinical Chemistry and Laboratory Medicine (CCLM). 42(3). 305–6. 4 indexed citations
18.
Oláh, Anna V., et al.. (2003). Urinary Homogentisic Acid in Alkaptonuric and Healthy Children. Clinical Chemistry and Laboratory Medicine (CCLM). 41(3). 356–9. 12 indexed citations
19.
Oláh, Anna V., P Buchmann, & F Largiadèr. (1989). [Can truncal vagotomy still be justified?].. PubMed. 55(5). 571–6. 1 indexed citations
20.
Oláh, Anna V., János Harangi, & András Lipták. (1988). Synthesis of everninose, a non-reducing disaccharide component of the orthosomycin-type oligosaccharide antibiotics. Carbohydrate Research. 174. 113–120. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesca Leone Breakdown of academic impact, for papers by Takao Sato Breakdown of academic impact, for papers by K Ishii Breakdown of academic impact, for papers by Hüseyin Beğenik Breakdown of academic impact, for papers by Tadashi Miyahara Breakdown of academic impact, for papers by Francisco Azzato Breakdown of academic impact, for papers by Ching‐Shan Huang Breakdown of academic impact, for papers by Anita Markotić Breakdown of academic impact, for papers by Jingchao Liu
Rankless by CCL
2026